SEC Form 4 · accession 0001144204-15-051838

NANOVIRICIDES, INC. · NNVC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 13, 2015

Accepted (ET)

Aug 25, 2015 · 7:21 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001379006

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, par value $0.001^F1	Aug 13, 2015	P	800	$1.25	A	1,606,191	D
Common Stock, par value $0.001^F1	Aug 14, 2015	P	8,594	$1.25	A	1,614,785	D
Common Stock, par value $0.001^F1	Aug 17, 2015	P	5,244	$1.25	A	1,620,029	D
Common Stock, par value $0.001^F1	Aug 18, 2015	P	2,547	$1.25	A	1,622,576	D
Common Stock, par value $0.001^F1	Aug 19, 2015	P	300	$1.25	A	1,622,876	D
Common Stock, par value $0.001^F1	Aug 20, 2015	P	2,662	$1.25	A	1,625,538	D
Common Stock, par value $0.001^F1	Aug 21, 2015	P	29,853	$1.25	A	1,655,391	D

No Table II lines on this filing.

F1Includes 1,083,963 shares of Common Stock and warrants to purchase an additional 571,428 shares of Common Stock held by the Reporting Person and his wife. Does not include: 942,859 shares of Common Stock, warrants to purchase an additional 285,714 shares of Common Stock or an indeterminate number of shares of Common Stock issuable upon conversion of debentures held by Boniuk Interests, Ltd.; 571,431 shares of Common Stock held by the Boniuk Charitable Foundation; or 50,000 shares of Common Stock, 952,381 shares of Common Stock issuable upon conversion of a 10% Coupon Series C Convertible Debenture, or 187,000 shares of Series A Preferred Stock held by Milton Boniuk IRA, convertible into 654,500 shares of common stock, which are not readily convertible. Dr. Boniuk holds voting and dispositive power over the Boniuk Charitable Foundation, Boniuk Interests Ltd. and the Milton Boniuk IRA.